(NHC) National HealthCare - Ratings and Ratios

Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6359061008

NHC: Care, Nursing, Hospice, Therapy, Pharmacy, Management

National HealthCare Corporation (NHC) operates across a broad spectrum of healthcare services, catering to diverse patient needs. Established in 1971 and headquartered in Murfreesboro, Tennessee, NHC is a significant player in the healthcare facilities industry, listed on the NYSE MKT under the ticker symbol NHC.

The companys skilled nursing facilities provide comprehensive care, including licensed therapies such as physical, speech, respiratory, and occupational therapy. These services are crucial for patients recovering from strokes, heart attacks, orthopedic conditions, and neurological illnesses. Additionally, NHC offers specialized medical services, nutrition, social services, and rehabilitative care, addressing a wide range of patient requirements.

NHCs medical specialty units include memory care for those with Alzheimers and sub-acute nursing units for patients needing specialized attention. Their assisted living facilities offer personal care services, assisting with daily activities like dressing and medication management, while independent living facilities provide residential units designed for active seniors, complete with amenities like restaurants and social areas.

Expanding beyond facility-based care, NHCs homecare and hospice agencies provide medical support for those preferring to stay at home. Their behavioral health services address psychiatric and emotional disorders in both adults and geriatric patients. The company also operates pharmacies and offers managed care insurance solutions, enhancing their service portfolio.

Financially, NHC has a market capitalization of approximately $1.9 billion, with a P/E ratio of 15.44, reflecting a stable valuation. The companys diversified revenue streams, including management services and property leasing, position it strategically in the healthcare sector, benefiting from an aging population and increased demand for long-term care.

For investors, NHCs extensive service range and diversified operations provide stability and growth potential in the healthcare industry. Their strategic approach to patient care and operational efficiency underscores their commitment to both patient well-being and shareholder value.

For more information, visit their website at https://www.nhccare.com.

Additional Sources for NHC Stock

NHC Stock Overview

Market Cap in USD 1,421m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 1987-01-20

NHC Stock Ratings

Growth Rating 30.9
Fundamental 70.8
Dividend Rating 52.7
Rel. Strength 6.33
Analysts -
Fair Price Momentum 89.30 USD
Fair Price DCF 113.30 USD

NHC Dividends

Dividend Yield 12m 2.41%
Yield on Cost 5y 3.92%
Annual Growth 5y 3.07%
Payout Consistency 70.0%

NHC Growth Ratios

Growth Correlation 3m -58.2%
Growth Correlation 12m -31.8%
Growth Correlation 5y 65%
CAGR 5y 8.72%
CAGR/Max DD 5y 0.26
Sharpe Ratio 12m 1.37
Alpha -1.58
Beta 0.607
Volatility 25.53%
Current Volume 37.3k
Average Volume 20d 49.5k
What is the price of NHC stocks?
As of April 26, 2025, the stock is trading at USD 94.58 with a total of 37,335 shares traded.
Over the past week, the price has changed by +4.73%, over one month by +5.35%, over three months by -2.94% and over the past year by +6.60%.
Is National HealthCare a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, National HealthCare (NYSE MKT:NHC) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 70.76 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NHC as of April 2025 is 89.30. This means that NHC is currently overvalued and has a potential downside of -5.58%.
Is NHC a buy, sell or hold?
National HealthCare has no consensus analysts rating.
What are the forecast for NHC stock price target?
According to ValueRays Forecast Model, NHC National HealthCare will be worth about 98 in April 2026. The stock is currently trading at 94.58. This means that the stock has a potential upside of +3.65%.
Issuer Forecast Upside
Wallstreet Target Price 6.2 -93.5%
Analysts Target Price 6.2 -93.5%
ValueRay Target Price 98 3.6%